Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omalizumab in Non-Allergic Asthma
NCT00162773Phase 2Terminated
- Sponsor
- Johns Hopkins University
- Start
- Apr 2005
- Primary completion
- Sep 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of omalizumab in nonallergic asthma (NAA), sponsored by Johns Hopkins University. Started Apr 2005; status: terminated.
02
Drugs
omalizumab
03
Conditions
nonallergic asthma (NAA)
Beyond the preview
Go deeper on NCT00162773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00162773.